Hyperammonemia-induced changes in GAD65 and GAD67, and in the membrane expression of GAT3 and of the γ2, α2, and β3 subunits of GABAA receptors were a consequence of the enhanced activation of TrkB via the increased levels of BDNF (Figure 10). The gene discussed is GAD2; the disease is Hyperammonemia.